Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Language
Publication year range
1.
Ars pharm ; 64(4): 359-375, oct.-dic. 2023. ilus, tab
Article in English | IBECS | ID: ibc-225995

ABSTRACT

Introducción: Aquasome es un sistema portador de nanopartículas autoensamblado con tres capas. El sistema se compone de un núcleo sólido nanocristalino interno recubierto de oligómero polihidroxilado. Adsorbidas en la capa recubierta se encuentran moléculas de fármacos o compuestos bioquímicamente activos. El autoensamblaje en este sentido se refiere a la formación independiente de moléculas en patrones organizados, de larga duración y con enlaces no covalentes. nueva tecnología de administración de fármacos. El artículo aborda principalmente los procesos de formulación utilizados para crear nanoestructuras autoensambladas y sus diversas aplicaciones posibles. Método: En la búsqueda bibliográfica se utilizaron varias bases de datos en línea, incluidas Science Direct, Medline, Web of Science, Google Scholar y Scopus. Se realizaron búsquedas en los conjuntos de datos en busca de entradas de estudios hasta julio de 2023. El documento de revisión aborda especialmente muchos elementos de la formación de aquasomas por parte de varios investigadores que emplean métodos/técnicas modificadas como la coprecipitación, la autoprecipitación, la pulverización catódica, etc. También ilustra una variedad de campos de terapia en los que se ha reconocido que el aquasoma tiene una gran influencia, como el oxígeno y el transporte de extractos. Resultados: El núcleo sólido es responsable de brindar estabilidad estructural, mientras que el recubrimiento oligomérico es crucial para proteger contra la deshidratación y estabilizar las moléculas bioactivas. Este vehículo de administración de fármacos biodegradable a escala nanométrica muestra una tendencia a acumularse en el hígado y los músculos. La no modificación de la adsorción del fármaco en la superficie del aquasoma facilita una respuesta farmacológica rápida al permitir el reconocimiento sin obstrucciones del receptor en el sitio de acción. (AU)


Introduction: Aquasome is a self-assembled nanoparticulate carrier system with three layers. The system is made up of a polyhydroxy oligomer-coated inner nanocrystalline solid core. Adsorbed on the coated layer are drug mole-cules or biochemically active compounds. Self-assembly in this sense refers to the independent formation of mole-cules into organised, long-lasting, and non-covalently bonded patterns.This paper gives an overview of aquasome formation, covering structural properties, formulation methodologies, and the benefits and drawbacks of this novel drug delivery technology. The article primarily addresses the formulation processes used to create self-assembled nanostructures and their various possible applications.Method: Several online databases, including Science Direct, Medline, Web of Science, Google Scholar and Scopus, were used in the literature search. The datasets were searched for entries of studies up to July, 2023. The review paper especially addresses many elements of aquasome formation by various researchers employing methods/modified techniques such as co-precipitation, self-precipitation, sputtering, and and so forth. It also illustrates a variety of fields of therapy in which aquasome has been recognised to have a major influence, such as oxygen and extract carrier.Results: The solid core is responsible for providing structural stability, while the oligomeric coating is crucial for safeguarding against dehydration and stabilising the bioactive molecules. This biodegradable drug delivery vehicle at the nanoscale level exhibits a tendency to accumulate in the liver and muscles. The non-modification of drug adsorption onto the aquasome surface facilitates prompt pharmacological response by allowing unobstructed re-ceptor recognition at the action site. (AU)


Subject(s)
Humans , Drug Carriers , Calcium Phosphates , Nanoparticles/administration & dosage , Nanotechnology , Nanostructures , Drug Compounding
2.
Ibrain ; 9(4): 402-420, 2023.
Article in English | MEDLINE | ID: mdl-38680508

ABSTRACT

Numerous modalities exist through which the central nervous system (CNS) may sustain injury or impairment, encompassing traumatic incidents, stroke occurrences, and neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. Presently available pharmacological and therapeutic interventions are incapable of restoring or regenerating damaged CNS tissue, leading to substantial unmet clinical needs among patients with CNS ailments or injuries. To address and facilitate the recovery of the impaired CNS, cell-based repair strategies encompass multiple mechanisms, such as neuronal replacement, therapeutic factor secretion, and the promotion of host brain plasticity. Despite the progression of cell-based CNS reparation as a therapeutic strategy throughout the years, substantial barriers have impeded its widespread implementation in clinical settings. The integration of cell technologies with advancements in regenerative medicine utilizing biomaterials and tissue engineering has recently facilitated the surmounting of several of these impediments. This comprehensive review presents an overview of distinct CNS conditions necessitating cell reparation, in addition to exploring potential biomaterial methodologies that enhance the efficacy of treating brain injuries.

3.
Indian J Clin Biochem ; 35(3): 331-338, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32647411

ABSTRACT

Garcinia pedunculata Roxb. is an important medicinal plant of North Eastern (NE) region of India, having number of medicinal properties and used against various diseases in folk medicine. An empirical research was designed to carry out evaluation of hepatoprotective activity of the leaves of G. pedunculata with special reference to its putative protective role. Methanolic extract from the dried leaf powder of G. pedunculata Roxb. was prepared by hot continuous extraction method. The prepared extract was investigated at different dose levels for its hepatoprotective nature and further histopathological study was carried out to ascertain the degree of reversing the hepatotoxic manifestation induced by CCl4 (Carbon tetrachloride). LD50 values of the G. pedunculata Roxb. extract was found to be safe up to 2000 mg. The in vivo biological studies on serum and tissues of male Wister rats at the doses of 100 mg, 300 mg and 600 mg/kg body weight respectively was carried out taking Silymarin as standard. The methanolic extract of G. pedunculata Roxb, improved the cholesterol level along with significant improvement of SGPT (Serum Glutamate Pyruvate Transaminase), SGOT (Serum Glutamate Oxaloacetate Transaminase), ALP (Alkaline Phosphatase) and total protein in respect to Silymarin group. The test extract at the dose 600 mg/kg body weight was found to significantly reverse the elevated marker enzymes i.e. SGOT, SGPT, ALP indicating its hepatoprotective role. The higher dose extracts were also found to have pronounced effect on oxidative stress parameters such as GSH and catalase on CCl4 induced rats. The histopathological studies further augmented the protective activity of G. pedunculata leaf extract thereby endorsing the traditional usage of the plant.

4.
Indian J Clin Biochem ; 33(2): 190-195, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29651210

ABSTRACT

Alternanthera sessilis commonly known as 'sessile joy weed' or 'dwarf copperleaf' is found throughout the hotter parts of India up to an altitude of 1200 m2. In Assam, the plant has been traditionally used in the treatment of jaundice along with other ailments. The study focuses primarily on the evaluation of hepatoprotective activity of the plant with special references to its putative protective role in carbon tetrachloride induced liver injury on Wister albino rat. The in vivo hepatoprotective activity of the methanolic extract at the dose of 250 mg/kg body weight was highly effective in controlling SGPT, SGOT, ALP, serum cholesterol and serum bilirubin level as compared to silymarin. The said extract also significantly lowered the lipid profile caused by CCl4. The activity shown by methanolic extract of the whole plant of A. sessilis is of considered importance and thus justified its use in controlling hepatic diseases in traditional treatment system.

5.
Chin J Nat Med ; 12(3): 172-9, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24702802

ABSTRACT

AIM: In the present study, the anti-inflammatory and antioxidant activities of the methanol extract of Ruta graveolens leaves (RG-M) were evaluated using various in vivo and in vitro models. METHOD: For anti-inflammatory activity, RG-M was administered by the oral route (p.o.) in a carrageenan-induced paw edema model, and by the intraperitoneal route (i.p.) in an exudative inflammation model. In vitro inhibition of cyclooxygenase and lipoxygenase enzymes was evaluated. In vitro antioxidant activity was also examined. Endogenous antioxidant status was further evaluated by ferric reducing ability of plasma model. RESULTS: RG-M showed maximum inhibition of carrageenan-induced edema (100 mg·kg⁻¹ - 33.36%; 200 mg·kg⁻¹ - 45.32% and 400 mg·kg⁻¹ - 56.28%). In the exudative inflammation model, a significant reduction in leukocyte migration (200 mg·kg⁻¹ - 54.75% and 400 mg·kg⁻¹ - 77.97%) and protein exudation (200 mg·kg⁻¹ - 31.14% and 400 mg·kg⁻¹ - 49.91%) were observed. RG-M also exhibited inhibition of COX-1 (IC50 182.27 µg·mL⁻¹) and COX-2 (IC50 190.16 µg·mL⁻¹) as well as 5-LOX (IC50 215.71 µg·mL⁻¹). Antioxidant activity was significant with improved endogenous antioxidant status. CONCLUSION: The results demonstrated the anti-inflammatory and antioxidant activity of RG-M with potent inhibitory effects on the arachidonic acid pathways.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Antioxidants/therapeutic use , Arachidonic Acid/metabolism , Inflammation/drug therapy , Phytotherapy , Ruta , Animals , Anti-Inflammatory Agents/pharmacology , Antioxidants/pharmacology , Carrageenan , Cyclooxygenase 1/metabolism , Cyclooxygenase 2/metabolism , Cyclooxygenase Inhibitors/pharmacology , Cyclooxygenase Inhibitors/therapeutic use , Disease Models, Animal , Edema/drug therapy , Exudates and Transudates , Ferric Compounds/metabolism , Inflammation/metabolism , Leukocytes/metabolism , Lipoxygenase Inhibitors/pharmacology , Lipoxygenase Inhibitors/therapeutic use , Lipoxygenases/metabolism , Male , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Plant Leaves , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...